Sonova AG
sonova.comTotal trials
86
Active
4
Phase 3
1
Total enrollment
1,908
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Hearing Loss57
- Hearing Loss, Sensorineural13
- Sensorineural Hearing Loss5
- Hearing Loss, Bilateral5
- Ability, Spatial3
- Hearing Loss, Bilateral Sensorineural, Progressive3
- Tinnitus1
- Ear Mold Impression Procedure1
Frequently asked questions about Sonova AG
- How many clinical trials does Sonova AG have on ClinicalTrials.gov?
- Sonova AG is listed as the lead sponsor on 86 clinical trials in ClinicalTrials.gov, 4 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Sonova AG's trials are in Phase 3?
- 1 of Sonova AG's trials are in Phase 3.
- What therapeutic areas does Sonova AG focus on?
- Sonova AG's most-studied conditions on ClinicalTrials.gov are Hearing Loss, Hearing Loss, Sensorineural, Sensorineural Hearing Loss, Hearing Loss, Bilateral, Ability, Spatial.